This page contains brief information about ivosidenib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Ivosidenib is approved to treat:
- Acute myeloid leukemia (AML) that has relapsed (come back) or is refractory (does not respond to treatment). It is used in adult patients whose AML has a certain mutation in the isocitrate dehydrogenase-1 (IDH1) gene.
Ivosidenib is also being studied in the treatment of other types of cancer.
More About Ivosidenib
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Ivosidenib - Check for trials from NCI's list of cancer clinical trials now accepting patients.